Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

e antigen in acute hepatitis B.

G Norkrans, L Magnius, S Iwarson

    British Medical Journal
    |March 27, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Hepatitis B e antigen presence correlates with longer detectable Hepatitis B surface antigen (HBs Ag) levels in acute infections. E antigen may also indicate a higher risk of developing chronic liver disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Activated Cellular Immunity in Chronic Hepatitis C.

    Hematology (Amsterdam, Netherlands)·2016
    Same author

    Long-term follow-up of successful hepatitis C virus therapy: waning immune responses and disappearance of liver disease are consistent with cure.

    Alimentary pharmacology & therapeutics·2015
    Same author

    Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

    Journal of viral hepatitis·2013
    Same author

    Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin.

    Journal of viral hepatitis·2013
    Same author

    Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV infection.

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2011
    Same author

    IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

    Journal of viral hepatitis·2011
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Hepatitis B virus (HBV) infection is a major global health concern.
    • Hepatitis B e antigen (HBeAg) and Hepatitis B surface antigen (HBsAg) are key viral markers.
    • Understanding their interplay is crucial for managing HBV infection.

    Purpose of the Study:

    • To investigate the association between HBeAg and HBsAg levels and duration in acute viral hepatitis type B.
    • To explore the prognostic significance of HBeAg in the development of chronic liver disease.

    Main Methods:

    • Study involved 90 inpatients diagnosed with acute viral hepatitis type B.
    • Serum samples were analyzed for the presence of HBeAg and HBsAg.
    • HBsAg subtypes and liver function tests were assessed.

    Related Experiment Videos

  • Clinical and histological signs of chronic liver disease were monitored.

    • Main Results:

    • HBeAg was detected in 24 patients.
    • Patients with HBeAg showed significantly longer detectable HBsAg levels.
    • HBsAg subtypes (adw, ayw) and acute phase liver function tests did not differ between groups.
    • Three of five patients progressing to chronic liver disease were HBeAg positive.

    Conclusions:

    • HBeAg presence is associated with prolonged HBsAg detectability in acute hepatitis B.
    • HBeAg positivity may serve as a prognostic marker for the development of chronic liver disease in hepatitis B patients.